Comparison effectiveness of use antihypertensive in preeclampsia patient in RSUD Panembahan Senopati Bantul

Andriana Sari, Wisi Unggul Pertiwi, Faridah Baroroh

Abstract


Preeclampsia is one of many unsolved obstetric problems. The purpose of this research is to compare effectiveness of antihypertensive in preeclampsia patient in RSUD Panembahan Senopati Bantul in the period January-July 2019. This study needs to analyze about antihypertensive drugs in preeclampsia because Preeclampsia is the 3rd rank of disease in pregnancy that causes maternal death after hemorrhagic and cardiovascular diseases. The study was conducted at Panembahan Senopati Hospital Bantul because hypertension in inpatient was ranked first in 10 distributions of non-communicable diseases. The research was observational analytic using a cross sectional study with retrospective data collection of patient medical record. Samples were selected on inclusion and exclusion criteria in 46 cases. Data analysis using Mann-Whitney to determine differences in drug effectiveness and Fisher's to determine the relationship. The results are found that no relationship between maternal age, obstetrical age, pregnancy status, method of birth, and length of stay, but there was a relationship between the severity of preeclampsia with the achievement of blood pressure targets. The results of comparative analysis of the effectiveness nifedipine monotherapy with combination of nifedipine + methyldopa there was a significant difference (p = 0.006), and there was a significant relationship between nifedipine monotherapy and combination of nifedipine + methyldopa (p = 0.015) OR results = 7.200. The conclusion of this study is more effective to use the combination of nifedipine + methyldopa for patients with preeclampsia.


Keywords


preeclampsia; drug effectiveness; antihypertension; nifedipine monotherapy; combination of nifedipine and methyldopa

Full Text:

PDF

References


Ainuddin, J., Javed, F., & Kazi, S. (2019). Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. Pakistan Journal of Medical Sciences, 35(5), 1428–1433. https://doi.org/10.12669/pjms.35.5.812

Alatas Haidar. (2019). Hipertensi Pada Kehamilan. Herb Medicine Journal, 2, 4005–4008. https://core.ac.uk/download/pdf/234099598.pdf

Bangkele, E. Y., Lintin, G., & Anjar, S. A. (2016). Analisis Faktor-Faktor Yang Berhubungan Dengan Preeklamsia Pada Ibu Hamil Di Rumah Sakit Undata Palu Tahun 2014. Jurnal Ilmiah Kedokteran, 3(1), 52–62.

CunninghamF, Gary, Kenneth J., Leveno, Steven L., Bloom, John C., H., & Dwight J., Rouse, Catherine Y., S. (2014). Williams OBSTETRICS 24rd Edition.

Dinkes Bantul. (2019). Profil Kesehatan Kab. Bantul. Profil Kesehatan Kabupaten Bantul 2019, 13(1), 15–20.

ESC. (2018). 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. In European Heart Journal (Vol. 39, Issue 34). https://doi.org/10.1093/eurheartj/ehy340

Grum, T., Seifu, A., Abay, M., Angesom, T., & Tsegay, L. (2017). Determinants of pre-eclampsia/Eclampsia among women attending delivery Services in Selected Public Hospitals of Addis Ababa, Ethiopia: A case control study. BMC Pregnancy and Childbirth, 17(1), 1–7. https://doi.org/10.1186/s12884-017-1507-1

Guerrier, G., Oluyide, B., Keramarou, M., & Grais, R. F. (2013). Factors associated with severe preeclampsia and eclampsia in Jahun, Nigeria. International Journal of Women’s Health, 5(1), 509–513. https://doi.org/10.2147/IJWH.S47056

Haskel, Irit Schushan-Eisen, Yigal Hass, Roni Rahav, Ayala Maayan-Metzger, I. H. (2018). Characteristics and severity of preeclampsia in young and elderly gravidas with hypertensive disease. European Journal of Obstetrics and Gynecology and Reproductive Biology, 228, 120–125. https://doi.org/10.1016/j.ejogrb.2018.05.038

Indhayani, L. (2018). Studi Penggunaan Obat Antihipertensi Pada Wanita Hamil Yang DIdiagnosis Hipertensi Di Rumah Sakit PMI Kota Bogor. JSTFI Indonesian Journal of Pharmaceutical Science and Technology, 7(1), 12–13.

JNC 8. (2014). JNC 8 Hypertension Guideline Algorithm. 311(5).

Julianti, N. (2017). GAMBARAN IBU BERSALIN DENGAN PREEKLAMSIA DI RUMAH SAKIT UMUM DAERAH SLEMAN YOGYAKARTA TAHUN 2016.

Miasih, K. (2016). Pola Peresepan Antihipertensi Pada Pasien Preeklampsia Di Instalasi Rawat Inap Rsud Wates Kulon Progo Periode Juli- Oktober 2014 Prescribing Pattern Antihypertensive in the Installation in Preeclamptic Patients Inpatient Hospital Wates , Kulon Progo Perio. 1(1), 47–53.

Muthoharoh, Siti., Virgia, V. (2016). STUDI KORELASI PARITAS DENGAN KEJADIAN PRE EKLAMSI PADA IBU HAMIL DI PUSKESMAS GAYAMAN KABUPATEN MOJOKERTO. Jurnal Keperawatan, 40–46.

Nandini, G., & Fernandes, J. (2016). Antihypertensives in Preeclampsia. International Journal of Science and Research (IJSR), 5(2), 1778–1781. https://doi.org/10.21275/v5i2.nov161578

Pratiwi, R., & Dewantiningrum, J. (2013). EFEKTIVITAS KOMBINASI NIFEDIPIN 10 mg DAN METILDOPA 500 mg TERHADAP LUARAN MATERNAL DALAM PENGELOLAAN PREEKLAMPSIA BERAT DI RSUP DR. KARIADI. Jurnal Kedokteran Diponegoro, 2(1), 106731.

Prawirohardjo, S. (2018). Hipertensi dalam kehamilan : Ilmu Kebidanan Edisi Keempat. PT Bina Pustaka. Jakarta.

Queensland Clinical Guidelines. (2015). Queensland Clinical Guidelines (QCG) Maternity and Neonatal Clinical Guideline Hypertensive disorders of pregnancy. Queensland Health, 1–32. https://www.health.qld.gov.au/qcg/documents/g-hdp.pdf

van der Tuuk, K., Tajik, P., Koopmans, C. M., van den Berg, P. P., Mol, B. W. J., van Pampus, M. G., & Groen, H. (2017). Blood pressure patterns in women with gestational hypertension or mild preeclampsia at term. European Journal of Obstetrics and Gynecology and Reproductive Biology, 210, 360–365. https://doi.org/10.1016/j.ejogrb.2017.01.021

Velusamy, S. (2017). Comparison of Treatment Outcome of Antihypertensive Drugs in the Management of Pregnancy Induced Hypertension. International Journal of Pharmacy and Pharmaceutical Sciences, 9(3), 287. https://doi.org/10.22159/ijpps.2017v9i3.15889




DOI: http://dx.doi.org/10.12928/pharmaciana.v13i2.23603

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Andriana Sari, M.Sc, Wisi Unggul Pertiwi, Farida Baroroh

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 
Pharmaciana
ISSN Print: 2088-4559 | ISSN Online: 2477-0256
Website: http://journal.uad.ac.id/index.php/PHARMACIANA
Office: Faculty of  Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id